Logo image of AMRQ.CA

AMAROQ LTD (AMRQ.CA) Stock Fundamental Analysis

Canada - TSX-V:AMRQ - CA02311U1030 - Common Stock

1.34 CAD
+0.06 (+4.69%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

2

Overall AMRQ gets a fundamental rating of 2 out of 10. We evaluated AMRQ against 807 industry peers in the Metals & Mining industry. AMRQ may be in some trouble as it scores bad on both profitability and health. AMRQ is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AMRQ has reported negative net income.
AMRQ had a negative operating cash flow in the past year.
AMRQ had negative earnings in each of the past 5 years.
AMRQ had a negative operating cash flow in each of the past 5 years.
AMRQ.CA Yearly Net Income VS EBIT VS OCF VS FCFAMRQ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a decent Return On Assets value of -7.39%, AMRQ is doing good in the industry, outperforming 64.81% of the companies in the same industry.
AMRQ's Return On Equity of -9.43% is fine compared to the rest of the industry. AMRQ outperforms 65.43% of its industry peers.
Industry RankSector Rank
ROA -7.39%
ROE -9.43%
ROIC N/A
ROA(3y)-14.53%
ROA(5y)-24%
ROE(3y)-15.86%
ROE(5y)-25.71%
ROIC(3y)N/A
ROIC(5y)N/A
AMRQ.CA Yearly ROA, ROE, ROICAMRQ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

AMRQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMRQ.CA Yearly Profit, Operating, Gross MarginsAMRQ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for AMRQ has been increased compared to 1 year ago.
AMRQ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMRQ has an improved debt to assets ratio.
AMRQ.CA Yearly Shares OutstandingAMRQ.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
AMRQ.CA Yearly Total Debt VS Total AssetsAMRQ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 5.82 indicates that AMRQ is not in any danger for bankruptcy at the moment.
AMRQ has a better Altman-Z score (5.82) than 63.57% of its industry peers.
AMRQ has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.15, AMRQ is not doing good in the industry: 65.30% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 5.82
ROIC/WACCN/A
WACCN/A
AMRQ.CA Yearly LT Debt VS Equity VS FCFAMRQ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 0.84 indicates that AMRQ may have some problems paying its short term obligations.
AMRQ's Current ratio of 0.84 is on the low side compared to the rest of the industry. AMRQ is outperformed by 62.33% of its industry peers.
AMRQ has a Quick Ratio of 0.84. This is a bad value and indicates that AMRQ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AMRQ (0.55) is worse than 66.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.55
AMRQ.CA Yearly Current Assets VS Current LiabilitesAMRQ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

AMRQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.05%.
EPS 1Y (TTM)-40.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AMRQ will show a very strong growth in Earnings Per Share. The EPS will grow by 68.15% on average per year.
AMRQ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 285.10% yearly.
EPS Next Y193.07%
EPS Next 2Y96.5%
EPS Next 3Y68.15%
EPS Next 5YN/A
Revenue Next Year3499.53%
Revenue Next 2Y578.62%
Revenue Next 3Y285.1%
Revenue Next 5YN/A

3.3 Evolution

AMRQ.CA Yearly Revenue VS EstimatesAMRQ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2024 2025 2026 2027 50M 100M 150M
AMRQ.CA Yearly EPS VS EstimatesAMRQ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMRQ. In the last year negative earnings were reported.
AMRQ is valuated reasonably with a Price/Forward Earnings ratio of 11.99.
Based on the Price/Forward Earnings ratio, AMRQ is valued cheaper than 91.20% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.71. AMRQ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 11.99
AMRQ.CA Price Earnings VS Forward Price EarningsAMRQ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMRQ.CA Per share dataAMRQ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMRQ's earnings are expected to grow with 68.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y96.5%
EPS Next 3Y68.15%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AMRQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMAROQ LTD

TSX-V:AMRQ (9/16/2025, 7:00:00 PM)

1.34

+0.06 (+4.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-14 2025-11-14
Inst Owners20.23%
Inst Owner ChangeN/A
Ins Owners6.82%
Ins Owner ChangeN/A
Market Cap608.51M
Analysts84
Price Target128.52 (9491.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)154.65%
EPS NY rev (3m)154.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)23.31%
Revenue NY rev (3m)23.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.99
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB 3.08
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0.11
Fwd EY8.34%
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.39%
ROE -9.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.53%
ROA(5y)-24%
ROE(3y)-15.86%
ROE(5y)-25.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11333%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.55
Altman-Z 5.82
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5033.11%
Cap/Depr(5y)3667.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.98%
EPS Next Y193.07%
EPS Next 2Y96.5%
EPS Next 3Y68.15%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year3499.53%
Revenue Next 2Y578.62%
Revenue Next 3Y285.1%
Revenue Next 5YN/A
EBIT growth 1Y25.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2117.85%
EBIT Next 3Y367.44%
EBIT Next 5YN/A
FCF growth 1Y-465.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.92%
OCF growth 3YN/A
OCF growth 5YN/A